- Home
- PAXS vs AVNS Comparison
PAXS vs AVNS Comparison
Compare PAXS & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAXS
- AVNS
- Stock Information
- Founded
- PAXS 2021
- AVNS 2014
- Country
- PAXS United States
- AVNS United States
- Employees
- PAXS N/A
- AVNS N/A
- Industry
- PAXS Investment Managers
- AVNS Industrial Specialties
- Sector
- PAXS Finance
- AVNS Health Care
- Exchange
- PAXS Nasdaq
- AVNS Nasdaq
- Market Cap
- PAXS 722.0M
- AVNS 731.6M
- IPO Year
- PAXS N/A
- AVNS N/A
- Fundamental
- Price
- PAXS $15.58
- AVNS $15.91
- Analyst Decision
- PAXS
- AVNS Hold
- Analyst Count
- PAXS 0
- AVNS 1
- Target Price
- PAXS N/A
- AVNS N/A
- AVG Volume (30 Days)
- PAXS 195.0K
- AVNS 583.6K
- Earning Date
- PAXS 01-01-0001
- AVNS 02-18-2025
- Dividend Yield
- PAXS 11.72%
- AVNS N/A
- EPS Growth
- PAXS N/A
- AVNS N/A
- EPS
- PAXS N/A
- AVNS 0.34
- Revenue
- PAXS N/A
- AVNS $681,500,000.00
- Revenue This Year
- PAXS N/A
- AVNS $3.84
- Revenue Next Year
- PAXS N/A
- AVNS $4.37
- P/E Ratio
- PAXS N/A
- AVNS $33.80
- Revenue Growth
- PAXS N/A
- AVNS N/A
- 52 Week Low
- PAXS $12.57
- AVNS $14.98
- 52 Week High
- PAXS $15.93
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- PAXS 46.66
- AVNS 40.49
- Support Level
- PAXS $15.29
- AVNS $15.61
- Resistance Level
- PAXS $15.93
- AVNS $16.26
- Average True Range (ATR)
- PAXS 0.25
- AVNS 0.53
- MACD
- PAXS 0.02
- AVNS 0.17
- Stochastic Oscillator
- PAXS 59.77
- AVNS 69.40
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.